Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Jun
04
Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps
Jun
03
Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis
Jun
01
UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members
May
19
BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in psoriatic arthritis: BE BOLD Week 16 data
May
14
UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States
May
04
UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers
Apr
17
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
Apr
15
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
Apr
13
UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026 American Academy of Neurology (AAN) meeting
